×
More Charts Below
Nephros Basic Shares Outstanding 2010-2024 | NEPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Recent Trends
Nephros basic shares outstanding from 2010 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
Historical Chart (TTM)
Quarterly
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$227.2B
Boston Scientific (BSX)
$140.7B
Stryker (SYK)
$132.3B
EssilorLuxottica (ESLOY)
$128.4B
Medtronic (MDT)
$105.9B
Lonza Group Ag (LZAGY)
$47.4B
Haleon (HLN)
$46.2B
ResMed (RMD)
$31.3B
Agilent Technologies (A)
$29.2B
GE HealthCare Technologies (GEHC)
$28.6B
Terumo (TRUMY)
$28.2B
Koninklijke Philips (PHG)
$22.2B
Zimmer Biomet Holdings (ZBH)
$19.4B
Insulet (PODD)
$17.3B
Baxter (BAX)
$14.8B
Smith & Nephew SNATS (SNN)
$11.4B
Sunny Optical Technology (SNPTF)
$7.6B
Lantheus Holdings (LNTH)
$6.9B
Bio-Rad Laboratories (BIO)
$6.7B
Demant (WILYY)
$6.6B
Prestige Consumer Healthcare (PBH)
$4B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Perrigo (PRGO)
$3.5B
ICU Medical (ICUI)
$3.4B
Haemonetics (HAE)
$2.9B
Envista Holdings (NVST)
$2.6B
GN Store Nord (GNNDY)
$2.2B
LeMaitre Vascular (LMAT)
$1.9B
QuidelOrtho (QDEL)
$1.7B
AtriCure (ATRC)
$1.6B